Biliary Disease, Chronic Total Occlusions, Claudication, Interventional Radiology, Liver Disease, Lower Extremity Angioplasty, Lower Extremity Stenting, Neuroendocrine Tumors, Peripheral Arterial Disease, Peripheral Vascular Disease, Renal Artery Disease, Renal Vascular Disease, Varicocele, Vascular and Interventional Radiology, Vascular Malformations, Venous Thromboembolism, Visceral Angioplasty, Visceral Stenting
Dr. Jean-Francois (Jeff) Geschwind is a Professor in the Johns Hopkins Medicine Department of Radiology and Department of Oncology.
Dr. Geschwind’s expertise focuses on treating hepatic cancer and other malignancies. He is considered a key opinion leader in the field of liver cancer.
A native of France, Dr. Geschwind received his medical degree from Boston University School of Medicine in 1991. He performed his residency training as a research scholar (sponsored by the NIH) in diagnostic radiology at the University of California at San Francisco (UCSF) in 1996, where his research focused on cardiac magnetic resonance imaging. Dr. Geschwind completed his training in vascular and interventional radiology at Johns Hopkins and joined the faculty in 1998 as an Assistant Professor.
He has authored or co-authored more than 350 published scientific articles and abstracts on interventional oncology and specifically the treatment of liver cancer. Dr. Geschwind also co-authored the first book dedicated to interventional oncology, titled Interventional Oncology Principles and Practice.
Dr. Geschwind has won numerous national and international awards, including the Merit Award from the American Society of Clinical Oncology for pioneering work in the field of drug delivery for liver cancer. He serves as the Consultant to the Editor of the journal Radiology, which has long been recognized as the premier radiology journal, and is on several editorial boards. He is also a founding member of the International Liver Cancer Association and is an active member of many other associations including the American Society of Clinical Oncology.